Mannosylated LigANI produced in Pichia pastoris protects hamsters against leptospirosis

Current Microbiology

Volumn 68, Issue 4, 2014, Pages 524-530

  Hartwig, Daiane D ^a,b   Bacelo, Kátia L ^a   De Oliveira, Patrícia D ^a   Oliveira, Thaís L ^a   Seixas, Fabiana K ^a   Amaral, Marta G ^a   Hartleben, Cláudia P ^a   McBride, Alan J A ^a,c   Dellagostin, Odir A ^a  

^a FEDERAL UNIVERSITY OF PELOTAS   (Brazil)

^b Instituto de Biologia   (Brazil)

^c INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALS; ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BIOREACTORS; CRICETINAE; FEMALE; LEPTOSPIRA; LEPTOSPIROSIS; PICHIA; RECOMBINANT PROTEINS; SURVIVAL ANALYSIS;

EID: 84893959568     PISSN: 03438651     EISSN: 14320991     Source Type: Journal    
DOI: 10.1007/s00284-013-0505-4     Document Type: Article

References (42)

1. Adler B, de la Pena MA (2010) Leptospira and leptospirosis. Vet Microbiol 140:287-296
2. Bharti AR, Nally JE, Ricaldi JN et al (2003) Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3:757-771
3. McBride AJ, Athanazio DA, Reis MG et al (2005) Leptospirosis. Curr Opin Infect Dis 18:376-386
4. Haake DA, Dundoo M, Cader R et al (2002) Leptospirosis, water sports, and chemoprophylaxis. Clin Infect Dis 34:e40-e43
5. Monahan AM, Miller IS, Nally JE (2009) Leptospirosis: risks during recreational activities. J Appl Microbiol 107:707-716
6. Reis RB, Ribeiro GS, Felzemburgh RD et al (2008) Impact of environment and social gradient on Leptospira infection in urban slums. PLoS Negl Trop Dis 2:e228
7. WHO (2011) Leptospirosis: an emerging public health problem. Wkly Epidemiol Rec 86:45-50
8. Gouveia EL, Metcalfe J, de Carvalho AL et al (2008) Leptospirosis- associated severe pulmonary hemorrhagic syndrome, Salvador, Brazil. Emerg Infect Dis 14:505-508
9. Segura ER, Ganoza CA, Campos K et al (2005) Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis 40:343-351
10. Faine SB, Adler B, Bolin C, Perolat P (1999) Leptospira and Leptospirosis, 2nd edn. MediSci, Melbourne
11. Dellagostin OA, Grassmann AA, Hartwig DD et al (2011) Recombinant vaccines against leptospirosis. Hum Vaccin 7:1215-1224
12. Matsunaga J, Barocchi MA, Croda J et al (2003) Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Mol Microbiol 49:929-945
13. Choy HA, Kelley MM, Chen TL et al (2007) Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect Immun 75:2441-2450
14. Choy HA, Kelley MM, Croda J et al (2011) The multifunctional LigB adhesin binds homeostatic proteins with potential roles in cutaneous infection by pathogenic Leptospira interrogans. PLoS One 6:e16879
15. Cerqueira GM, McBride AJ, Hartskeerl RA et al (2010) Bioinformatics describes novel Loci for high resolution discrimination of Leptospira isolates. PLoS One 5:e15335
16. McBride AJ, Cerqueira GM, Suchard MA et al (2009) Genetic diversity of the Leptospiral immunoglobulin-like (Lig) genes in pathogenic Leptospira spp. Infect Genet Evol 9:196-205
17. Koizumi N, Watanabe H (2004) Leptospiral immunoglobulin-like proteins elicit protective immunity. Vaccine 22:1545-1552
18. Lucas DS, Cullen PA, Lo M et al (2011) Recombinant LipL32 and LigA from Leptospira are unable to stimulate protective immunity against leptospirosis in the hamster model. Vaccine 29:3413-3418
19. Palaniappan RU, McDonough SP, Divers TJ et al (2006) Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 74:1745-1750
20. Silva EF, Medeiros MA, McBride AJ et al (2007) The terminal portion of leptospiral immunoglobulin-like protein LigA confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine 25:6277-6286
21. Coutinho ML, Choy HA, Kelley MM et al (2011) A LigA three-domain region protects hamsters from lethal infection by Leptospira interrogans. PLoS Negl Trop Dis 5:e1422
22. Hartwig DD, Oliveira TL, Seixas FK et al (2010) High yield expression of leptospirosis vaccine candidates LigA and LipL32 in the methylotrophic yeast Pichia pastoris. Microb Cell Fact 9:98
23. Cereghino GP, Cereghino JL, Ilgen C et al (2002) Production of recombinant proteins in fermenter cultures of the yeast Pichia pastoris. Curr Opin Biotechnol 13:329-332
24. Macauley-Patrick S, Fazenda ML, McNeil B et al (2005) Heterologous protein production using the Pichia pastoris expression system. Yeast 22:249-270
25. Cregg JM, Cereghino JL, Shi J et al (2000) Recombinant protein expression in Pichia pastoris. Mol Biotechnol 16:23-52
26. Ko AI, Galvao RM, Ribeiro Dourado CM et al (1999) Urban epidemic of severe leptospirosis in Brazil. Salvador leptospirosis study group. Lancet 354:820-825
27. Reed LJ (1938) A simple method of estimating fifty percent endpoints. Am J Hyg 27:493-497
28. Seixas FK, da Silva EF, Hartwig DD et al (2007) Recombinant Mycobacterium bovis BCG expressing the LipL32 antigen of Leptospira interrogans protects hamsters from challenge. Vaccine 26:88-95
29. Chagas-Junior AD, McBride AJ, Athanazio DA et al (2009) An imprint method for detecting leptospires in the hamster model of vaccine-mediated immunity for leptospirosis. J Med Microbiol 58:1632-1637
30. Cereghino JL, Cregg JM (2000) Heterologous protein expression in the methylotrophic yeast Pichia pastoris. FEMS Microbiol Rev 24:45-66
31. Faisal SM, Yan W, Chen CS et al (2008) Evaluation of protective immunity of Leptospira immunoglobulin like protein A (LigA) DNA vaccine against challenge in hamsters. Vaccine 26:277-287
32. Faisal SM, Yan W, McDonough SP et al (2009) Leptospira immunoglobulin-like protein A variable region (LigAvar) incorporated in liposomes and PLGA microspheres produces a robust immune response correlating to protective immunity. Vaccine 27:378-387
33. Palaniappan RU, McDonough SP, Divers TJ et al (2006) Immunoprotection of recombinant leptospiral immunoglobulin-like protein A against Leptospira interrogans serovar Pomona infection. Infect Immun 74:1745-1750
34. Palaniappan RU, Chang YF, Jusuf SS et al (2002) Cloning and molecular characterization of an immunogenic LigA protein of Leptospira interrogans. Infect Immun 70:5924-5930
35. Raemaekers RJ, de Muro L, Gatehouse JA, Fordham-Skelton AP (1999) Functional phytohemagglutinin (PHA) and Galanthus nivalis agglutinin (GNA) expressed in Pichia pastoris correct N-terminal processing and secretion of heterologous proteins expressed using the PHA-E signal peptide. Eur J Biochem 265:394-403
36. Daly R, Hearn MT (2005) Expression of heterologous proteins in Pichia pastoris: a useful experimental tool in protein engineering and production. J Mol Recognit 18:119-138
37. Montesino R, Garcia R, Quintero O et al (1998) Variation in N-linked oligosaccharide structures on heterologous proteins secreted by the methylotrophic yeast Pichia pastoris. Protein Expr Purif 14:197-207
38. Rudd PM, Elliott T, Cresswell P et al (2001) Glycosylation and the immune system. Science 291:2370-2376
39. Bretthauer RK, Castellino FJ (1999) Glycosylation of Pichia pastoris-derived proteins. Biotechnol Appl Biochem 30(Pt 3):193-200
40. Trimble RB, Lubowski C, Hauer CR III et al (2004) Characterization of N- and O-linked glycosylation of recombinant human bile salt-stimulated lipase secreted by Pichia pastoris. Glycobiology 14:265-274
41. Lam JS, Mansour MK, Specht CA et al (2005) A model vaccine exploiting fungal mannosylation to increase antigen immunogenicity. J Immunol 175:7496-7503
42. Luong M, Lam JS, Chen J et al (2007) Effects of fungal N- and O-linked mannosylation on the immunogenicity of model vaccines. Vaccine 25:4340-4344